The investment is set to expand two facilities on US soil and is part of an overarching $50 billion commitment ...

The facility is designed the ease advanced therapy development and manufacturing for partners by offering closer ...

N-1 perfusion with XCell® ATF Systems increases upstream productivity and yields while using existing bioreactor ...